פוסטימון - Fostimon

פוסטימון - Fostimon
מרכיב פעיל	UROFOLLITROPHIN
קבוצה פרמקולוגית (ATC)	"GONADOTROPINS"
שם התרופה	"פוסטימון®" (קישור לדף התרופה במאגר משרד הבריאות)
סל הבריאות	לא כלול
התוויות	A treatment with FSH followed by the administration of human chronic gonadotrophin (HCG) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. These women belong to the WHO group II and have generally already been treated with clomiphene citrate. Most have polycystic ovarian syndrome. FSH offers good therapeutic prospects for patients whose LH:FSH ratio has to be adjusted, avoiding an exogenous supply of LH FSH may be used alone or in concomitance with human menopausal gonadotropin (HMG) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (IVF-ET,GIFT)
שם יצרן	IBSA INSTITUTE BIOCHIMIQUE SA, SWITZERLAND
שם בעל הרישום	TZAMAL BIO-PHARMA LTD
עלון לצרכן	"עלון לצרכן בעברית"